Bringing the fundamentals into focus…
Back to Inhibikase Therapeutics, Inc.
How Inhibikase Therapeutics, Inc. stacks up
IKT · against 245 other Healthcare companies of similar size
Profitability
17/ 100
Below the middle of the pack.
Ranked #174 of 246 · scores higher than 27% of peers
Bars: peers in each 10-point band of the profitability score37 peers with a profitability score of 10–19, including IKT · Click a bar to see the companies
Why profitability scores 17?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 89% of peers. Return on assets: -37.1% vs peer median 1.7%
- a lower return on invested capital: weaker than 86% of peers. Return on invested capital: -42.3% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = IKT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IKT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 206 reported | -42.3% | -2.5% | 25% | 33% | |
| Operating marginHigher is better · 226 reported | Not reported | 0.7% | — | — | 33% |
| Return on assetsHigher is better · 250 reported | -37.1% | -1.8% | 16% | 33% | |
| Return on equityHigher is better · 232 reported | -52.0% | -4.8% | 21% | Context only | |
| Gross marginHigher is better · 263 reported | 0.0% | 37.1% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around IKT| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 172 | 118M USD | 18 | 13 | |
| 172 | 165M USD | 18 | 50 | |
| 174 | 222M GBP (≈$288M) | 17 | 13 | |
| 174 | 393M USD | 17 | 50 | |
| 174 | 207M USD | 17 | 41 | |
| 174 | 255M USD | 17 | 38 | |
| 174 | 276M USD | 17 | 46 | |
| 174 | 142M USD | 17 | 45 | |
| 180 | 302M USD | 16 | 17 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score